News Archive

/static/apps/cms/news/1416/Peter Ward 500.jpg

New Antibody Treatment Discovered by Ward Lab Approved by FDA

April 6, 2023 / Research

After several decades of hard work by many scientists at the University of Michigan Medical School and elsewhere, an antibody (anti-C5a) has just been approved by the US FDA for treatment of humans who are septic and have developed lung infections with COVID-19, resulting in severe pulmonary dysfunction requiring external lung support. The antibody, anti-C5a, was originally developed in the Dr. Peter Ward laboratory in the early 2000s. The mAb was shown to dramatically reduce lung infections in polymicrobial sepsis in mice. 

FULL STORY
/static/apps/cms/news/1327/images/banners/McAnulty-Header-LG.jpg

Pathology's Best Kept Secret: MCP Graduate Program

September 15, 2022 / Education

A Perspective with Jessica McAnulty, MCP Student

FULL STORY
/static/apps/cms/news/1109/Rohit-News-Header-1109.jpg

"A Correct Diagnosis Can Be Life-Changing": Dr. Rohit Mehra

March 9, 2021 / Careers In Pathology

Dr. Mehra discusses his career path and how he arrived at Michigan Medicine in our latest Careers in Pathology video.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1096/Udager_500x500.jpg

Research from Dr. Udager Published in European Urology

February 1, 2021 / Cancer

A new publication, generated by Department of Pathology faculty members Drs. Aaron Udager and Scott Tomlins was successfully published in European Urology. The research highlights a longitudinal cohort study centered around the serial molecular profiling of low-grade prostate cancer in order to better assess tumor upgrading [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1084/man-looking-in-microscope-500x500.jpg

Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead

December 22, 2020 / Cancer Research

Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus. wo proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, MD, PhD. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1060/Arul_500x500.jpg

ASIP Rous-Whipple Award Lecture: Arul Chinnaiyan, MD, PhD

October 1, 2020 / Events

11:30 am EST

Join us for a virtual event featuring the Department of Pathology's Dr. Arul Chinnaiyan, who will give the 2020 American Society for Investigative Pathology (ASIP)'s Rous-Whipple Award Lecture. 

Register Here

 

FULL STORY

Research Regarding Invasive Squamous Cell Carcinoma Published

May 29, 2020 / Experimental Pathology

The research, which focuses on invasive squamous cell carcinomas and the precursor lesions that demonstrate concordic genomic complexity in driver genes, was just published in Modern Pathology.

FULL STORY